A two-day workshop reviewing Canadian provincial and national HIV care cascade indicators, reporting, challenges, and recommendations.

Autor:	Nicolau IA; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Shokoohi M; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada., McBane JE; The Canadian HIV Trials Network (CTN), Vancouver, British Columbia, Canada.; The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Pogany L; Public Health Agency of Canada (PHAC), Ottawa, Ontario, Canada., Popovic N; Public Health Agency of Canada (PHAC), Ottawa, Ontario, Canada., Nicholson V; Communities, Alliances & Networks (CAAN), Montreal, Quebec, Canada.; British Columbia Centre for Excellence in HIV/AIDS Care (BC-CfE), Vancouver, British Columbia, Canada., Hillier S; The Canadian HIV Trials Network (CTN), Vancouver, British Columbia, Canada.; School of Health Policy and Management, York University, Toronto, Ontario, Canada., Aran N; British Columbia Centre for Excellence in HIV/AIDS Care (BC-CfE), Vancouver, British Columbia, Canada., Brophy J; The Canadian HIV Trials Network (CTN), Vancouver, British Columbia, Canada.; Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.; Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada., Burt K; HIV Program, Eastern Health, St. John's, Newfoundland, Canada., Cox J; The Canadian HIV Trials Network (CTN), Vancouver, British Columbia, Canada.; Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, Quebec, Canada.; McGill University, Montreal, Quebec, Canada., de Pokomandy A; The Canadian HIV Trials Network (CTN), Vancouver, British Columbia, Canada.; Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, Quebec, Canada.; McGill University, Montreal, Quebec, Canada., Kakkar F; The Canadian HIV Trials Network (CTN), Vancouver, British Columbia, Canada.; Centre de Recherche, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada., Kelly D; The Canadian HIV Trials Network (CTN), Vancouver, British Columbia, Canada.; Department of Pharmacy, Memorial University of Newfoundland, St. John's, Newfoundland, Canada., Kerkerian G; Infectious Diseases Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada., Kogilwaimath S; The Canadian HIV Trials Network (CTN), Vancouver, British Columbia, Canada.; University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Kroch A; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; The Canadian HIV Trials Network (CTN), Vancouver, British Columbia, Canada.; Ontario HIV Treatment Network, Toronto, Ontario, Canada., Dias Lima V; British Columbia Centre for Excellence in HIV/AIDS Care (BC-CfE), Vancouver, British Columbia, Canada., Linthwaite B; Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, Quebec, Canada., Mbuagbaw L; The Canadian HIV Trials Network (CTN), Vancouver, British Columbia, Canada.; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada., McClarty L; University of Manitoba, Winnipeg, Manitoba, Canada., Turvey S; University of Alberta, Edmonton, Alberta, Canada., Owino M; The Canadian HIV Trials Network (CTN), Vancouver, British Columbia, Canada.; Committee for Accessible AIDS Treatment, Toronto, Ontario, Canada.; York University, Toronto, Ontario, Canada., Martin C; The Canadian HIV Trials Network (CTN), Vancouver, British Columbia, Canada.; Communities, Alliances & Networks (CAAN), Montreal, Quebec, Canada.; Concordia, Montreal, Quebec, Canada., Hogg RS; The Canadian HIV Trials Network (CTN), Vancouver, British Columbia, Canada.; British Columbia Centre for Excellence in HIV/AIDS Care (BC-CfE), Vancouver, British Columbia, Canada.; Simon Fraser University, Vancouver, British Columbia, Canada., Loutfy M; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
Jazyk:	angličtina
Zdroj:	Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada [J Assoc Med Microbiol Infect Dis Can] 2022 Sep 27; Vol. 7 (3), pp. 247-268. Date of Electronic Publication: 2022 Sep 27 (Print Publication: 2022).
DOI:	10.3138/jammi-2022-0007
Abstrakt:	Background: The HIV care cascade is an indicators-framework used to assess achievement of HIV clinical targets including HIV diagnosis, HIV care initiation and retention, initiation of antiretroviral therapy, and attainment of viral suppression for people living with HIV. Methods: The HIV Care Cascade Research Development Team at the CIHR Canadian HIV Trials Network Clinical Care and Management Core hosted a two-day virtual workshop to present HIV care cascade data collected nationally from local and provincial clinical settings and national cohort studies. The article summarizes the workshop presentations including the indicators used and available findings and presents the discussed challenges and recommendations. Results: Identified challenges included (1) inconsistent HIV care cascade indicator definitions, (2) variability between the use of nested UNAIDS's targets and HIV care cascade indicators, (3) variable analytic approaches based on differing data sources, (4) reporting difficulties in some regions due to a lack of integration across data platforms, (5) lack of robust data on the first stage of the care cascade at the sub-national level, and (6) inability to integrate key socio-demographic data to estimate population-specific care cascade shortfalls. Conclusion: There were four recommendations: standardization of HIV care cascade indicators and analyses, additional funding for HIV care cascade data collection, database maintenance and analyses at all levels, qualitative interviews and case studies characterizing the stories behind the care cascade findings, and employing targeted positive-action programs to increase engagement of key populations in each HIV care cascade stage. (Copyright © 2022, Association of Medical Microbiology and Infectious Disease Canada (AMMI Canada).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu